Serum MRGPRX2 as a Long-term Biomarker for Iodinated Contrast Media-Induced Anaphylaxis
Open Access
- 1 January 2024
- journal article
- research article
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 16 (3) , 308-316
Abstract
An J, et al. Allergy Asthma Immunol Res. 2024 May;16(3):308-316. https://doi.org/10.4168/aair.2024.16.3.308Keywords
Funding Information
- Ministry of Health and Welfare (HI18C1392)
- National Research Foundation of Korea (2019M3E5D3073365)
This publication has 22 references indexed in Scilit:
- Skin Test–Guided Strategy to Select Alternative Iodinated Contrast Media in Patients With Immediate Hypersensitivity Reaction: A Prospective Confirmative StudyThe Journal of Allergy and Clinical Immunology: In Practice, 2023
- Novel insights into atopic dermatitisJournal of Allergy and Clinical Immunology, 2022
- Use and Interpretation of Acute and Baseline Tryptase in Perioperative Hypersensitivity and AnaphylaxisThe Journal of Allergy and Clinical Immunology: In Practice, 2021
- Non–IgE-mediated anaphylaxisJournal of Allergy and Clinical Immunology, 2021
- World Allergy Organization Anaphylaxis Guidance 2020World Allergy Organization Journal, 2020
- Phenotypes, endotypes and biomarkers in anaphylaxis: current insightsCurrent Opinion in Allergy and Clinical Immunology, 2018
- Roles of Mas-related G protein–coupled receptor X2 on mast cell–mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseasesJournal of Allergy and Clinical Immunology, 2016
- Human IgE-independent systemic anaphylaxisJournal of Allergy and Clinical Immunology, 2016
- Mast Cells and AnaphylaxisCurrent Allergy and Asthma Reports, 2016
- Drug-induced anaphylaxis: a decade review of reporting to the Portuguese Pharmacovigilance AuthorityEuropean Journal of Clinical Pharmacology, 2012